FDA approves new epinephrine nasal spray

The video discusses a newly FDA-approved epinephrine nasal spray, Nefi, as a needle-free option for treating severe allergic reactions like anaphylaxis. It highlights the drug's cost, target users, and the excitement among allergists. The rise in food allergies and the unknown reasons behind it are also mentioned. Nefi's approval is based on several studies, and it offers an alternative to EpiPens, potentially reducing treatment delays. The FDA requires ongoing research, and the spray is expected to be widely available soon.

What is the significance of the FDA's approval of the nasal spray for patients weighing 66 lbs and up?

What concerns do allergists have regarding the administration of EpiPens?